| Obesity II: Establishing causal links between chemical exposures and obesity JJ Heindel, S Howard, K Agay-Shay, JP Arrebola, K Audouze, PJ Babin, ... Biochemical Pharmacology 199, 115015, 2022 | 161 | 2022 |
| Obesity I: Overview and molecular and biochemical mechanisms RH Lustig, D Collier, C Kassotis, TA Roepke, MJ Kim, E Blanc, R Barouki, ... Biochemical Pharmacology 199, 115012, 2022 | 151 | 2022 |
| Developmental Exposure to Endocrine Disrupting Chemicals and Type 1 Diabetes Mellitus SG Howard Frontiers in Endocrinology 9, 513, 2018 | 62 | 2018 |
| What is the role of human contamination by environmental chemicals in the development of type 1 diabetes? SG Howard, DH Lee Journal of epidemiology and community health, jech. 2011.133694, 2011 | 55 | 2011 |
| Exposure to environmental chemicals and type 1 diabetes: an update SG Howard J Epidemiol Community Health 73 (6), 483-488, 2019 | 54 | 2019 |
| Developmental exposure to environmental chemicals and metabolic changes in children K Russ, S Howard Current problems in pediatric and adolescent health care 46 (8), 255-285, 2016 | 53 | 2016 |
| Obesogens: a unifying theory for the global rise in obesity JJ Heindel, RH Lustig, S Howard, BE Corkey International Journal of Obesity, 1-12, 2024 | 42 | 2024 |
| Obesity III: Obesogen assays: Limitations, strengths, and new directions CD Kassotis, FS Vom Saal, PJ Babin, D Lagadic-Gossmann, H Le Mentec, ... Biochemical Pharmacology 199, 115014, 2022 | 30 | 2022 |
| Environmental pollutants and beta cell function: relevance for type 1 and gestational diabetes SG Howard, JJ Heindel, KA Thayer, M Porta Diabetologia 54, 3168-3169, 2011 | 16 | 2011 |
| Association of bisphenol A with diabetes and other abnormalities S Howard, TG Howard JAMA 301 (7), 720-722, 2009 | 16 | 2009 |
| Obesogens and Obesity: State-of-the-Science and Future Directions Summary from a Healthy Environment and Endocrine Disruptors Strategies Workshop JJ Heindel, JA Alvarez, E Atlas, MC Cave, VL Chatzi, D Collier, B Corkey, ... The American Journal of Clinical Nutrition, 2023 | 9 | 2023 |
| The diabetes epidemic: environmental chemical exposure in etiology and treatment RM Sargis, SG Howard, RR Newbold, JJ Heindel San Francisco medicine 85 (5), 18, 2012 | 5 | 2012 |
| Comment on: Berhan. Thirty Years of Prospective Nationwide Incidence of Childhood Type 1 Diabetes: The Accelerating Increase by Time Tends to Level Off in Sweden. Diabetes 2011 … SG Howard Diabetes 60 (9), e25-e25, 2011 | 4 | 2011 |
| Type 1 diabetes—origins and epidemiology SG Howard, RM Sargis The Lancet Diabetes & Endocrinology 8 (5), 367-368, 2020 | 3 | 2020 |
| Corrigendum to" Obesity II: Establishing causal links between chemical exposures and obesity"[Biochem. Pharmacol. 199 (2022) 115015] JJ Heindel, S Howard, K Agay-Shay, JP Arrebola, K Audouze, PJ Babin, ... Biochemical pharmacology 202, 115144, 2022 | 1 | 2022 |
| Environmental Chemicals in Diabetes and Obesity: Unexplored Territory S Howard Physicians for Social Responsibility, 2014 | 1 | 2014 |
| Obesity and Diabetes: Role of Environmental Chemical Exposures TT Schug, SG Howard, KW Taylor, JJ Heindel Aging and Vulnerability to Environmental Chemicals, 201-240, 2012 | 1 | 2012 |
| Obesity III: Obesogen assays: Limitations, strengths, and new directions (vol 199, 115014, 2022) CD Kassotis, FS vom Saal, PJ Babin, D Lagadic-Gossmann, H Le Mentec, ... BIOCHEMICAL PHARMACOLOGY 202, 2022 | | 2022 |
| Corrigendum to “Obesity III: Obesogen assays: Limitations, strengths, and new directions”[Biochem. Pharmacol. 199 (2022) 115014] CD Kassotis, FS Vom Saal, PJ Babin, D Lagadic-Gossmann, H Le Mentec, ... Biochemical pharmacology 202, 115145, 2022 | | 2022 |
| Obesity II: Establishing causal links between chemical exposures and obesity (vol 199, 115015, 2022) JJ Heindel, S Howard, K Agay-Shay, JP Arrebola, K Audouze, PJ Babin, ... Biochemical Pharmacology 202, 2022 | | 2022 |
Duk-Hee LeeProfessor, Department of Preventive Medicine, School of Medicine, Kyungpook National Universityبريد إلكتروني تم التحقق منه على knu.ac.kr